1. Home
  2. BRTX vs BTBD Comparison

BRTX vs BTBD Comparison

Compare BRTX & BTBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRTX
  • BTBD
  • Stock Information
  • Founded
  • BRTX 1997
  • BTBD 1987
  • Country
  • BRTX United States
  • BTBD United States
  • Employees
  • BRTX N/A
  • BTBD N/A
  • Industry
  • BRTX Managed Health Care
  • BTBD Restaurants
  • Sector
  • BRTX Health Care
  • BTBD Consumer Discretionary
  • Exchange
  • BRTX Nasdaq
  • BTBD Nasdaq
  • Market Cap
  • BRTX 12.8M
  • BTBD 11.3M
  • IPO Year
  • BRTX N/A
  • BTBD 2021
  • Fundamental
  • Price
  • BRTX $1.50
  • BTBD $1.85
  • Analyst Decision
  • BRTX
  • BTBD
  • Analyst Count
  • BRTX 0
  • BTBD 0
  • Target Price
  • BRTX N/A
  • BTBD N/A
  • AVG Volume (30 Days)
  • BRTX 304.1K
  • BTBD 171.2K
  • Earning Date
  • BRTX 11-13-2025
  • BTBD 11-12-2025
  • Dividend Yield
  • BRTX N/A
  • BTBD N/A
  • EPS Growth
  • BRTX N/A
  • BTBD N/A
  • EPS
  • BRTX N/A
  • BTBD N/A
  • Revenue
  • BRTX $605,200.00
  • BTBD $14,533,449.00
  • Revenue This Year
  • BRTX $232.67
  • BTBD N/A
  • Revenue Next Year
  • BRTX $52.92
  • BTBD N/A
  • P/E Ratio
  • BRTX N/A
  • BTBD N/A
  • Revenue Growth
  • BRTX 247.62
  • BTBD 1.58
  • 52 Week Low
  • BRTX $1.19
  • BTBD $1.00
  • 52 Week High
  • BRTX $2.55
  • BTBD $5.60
  • Technical
  • Relative Strength Index (RSI)
  • BRTX 42.27
  • BTBD 50.11
  • Support Level
  • BRTX $1.49
  • BTBD $1.74
  • Resistance Level
  • BRTX $1.70
  • BTBD $2.10
  • Average True Range (ATR)
  • BRTX 0.09
  • BTBD 0.15
  • MACD
  • BRTX -0.01
  • BTBD 0.00
  • Stochastic Oscillator
  • BRTX 14.81
  • BTBD 34.69

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

About BTBD BT Brands Inc.

BT Brands Inc operates and owns a fast-food restaurant called Burger Time. The company also operates in Minnesota as a franchisee of Dairy Queen. It offers a variety of burgers and other affordably priced foods such as chicken sandwiches, pulled pork sandwiches, chicken chunks, side dishes, and soft drinks.

Share on Social Networks: